How Uber and Pinterest Investor Scott Belsky Finds Opportunity
Cheddar investor and entrepreneur Scott Belsky joined Cheddar at Cornell's Entrepreneurship Summit, and talked about how entrepreneurship has changed over the past decade.
Belsky said that design is now a competitive advantage, whereas ten years ago it was something you would outsource. He also said that starting and testing a company is easier than ever. The only drawback being a company's ability to scale, something he attributes to the mastering different social media platforms.
Belsky is invested in companies such as Uber, Pinterest, and Warby Parker. When looking for a company to invest in, he looks at its technology, how it might make new careers in the future, and for a concept that plays into the creative industry. He also looks at the team running the company. The team must be design-centric, take initiative, and listen.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.